Literature DB >> 11152653

Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction.

L D Mikus1, L A Rosenthal, R L Sorkness, R F Lemanske.   

Abstract

After parainfluenza type 1 (Sendai) virus infection as weanlings, Brown Norway (BN), unlike Fischer 344 (F344), rats develop an asthma-like phenotype. Reduced postinfection interferon (IFN)-gamma levels in bronchoalveolar lavage fluid from BN weanlings and the prevention of chronic airway sequelae in BN rats by IFN-gamma treatment led to the hypothesis that cells from BN weanlings have a reduced ability to secrete IFN-gamma. After stimulation with Sendai virus or interleukin (IL)-12, splenocytes from uninfected BN weanlings secreted significantly less IFN-gamma than did splenocytes from F344 weanlings (P < 0.005), as determined by enzyme-linked immunosorbent assay. Because levels of potential IFN-gamma-secreting cells in the spleen differed between the strains, natural killer (NK) cells, an important IFN-gamma source during early antiviral responses, were purified from spleens of uninfected weanlings. When stimulated with IL-12, BN NK cells secreted significantly less IFN-gamma than did F344 NK cells (P < 0.001). Incubation of NK cells from either strain with IL-12 and IL-18 resulted in synergistic increases in IFN-gamma production, but BN cells still secreted significantly less IFN-gamma than did F344 cells (P < 0.05). Similarly, after incubation with either IFN-alpha or IFN-alpha plus IL-18, BN NK cells secreted significantly less IFN-gamma than did F344 NK cells (P < 0.05). Therefore, reduced IFN-gamma secretion by NK cells in BN weanlings may play a role in the development of postviral chronic airway dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152653     DOI: 10.1165/ajrcmb.24.1.4125

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

Review 1.  Interleukin-35 in immune-related diseases: protection or destruction.

Authors:  Junfeng Zhang; Yunsheng Zhang; Qingpeng Wang; Chunlei Li; Hongxin Deng; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

2.  Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells.

Authors:  Véronique Sergent; Bastien Cautain; Jamal Khalife; Didier Deslée; Patrick Bastien; Anne Dao; Jean-François Dubremetz; Gilbert J Fournié; Abdelhadi Saoudi; Marie-France Cesbron-Delauw
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 3.  The ABCs of rhinoviruses, wheezing, and asthma.

Authors:  James E Gern
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

5.  Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells.

Authors:  M Aoyagi; N Shimojo; K Sekine; T Nishimuta; Y Kohno
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

6.  Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.

Authors:  Elizabeth A Hines; Renee J Szakaly; Ning Leng; Anais T Webster; Jamie M Verheyden; Amber J Lashua; Christina Kendziorski; Louis A Rosenthal; James E Gern; Ronald L Sorkness; Xin Sun; Robert F Lemanske
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

7.  Differences in Genetic Background Contribute to Pseudomonas Exotoxin A-Induced Hepatotoxicity in Rats.

Authors:  Chien-Chao Chiu; Yu-Chih Wang; Wen-Ching Huang; Yi-Hsun Chen; Shao-Wen Hung; Yen-Te Huang; Hsiao-Li Chuang; Yi-Chih Chang
Journal:  Toxins (Basel)       Date:  2017-07-15       Impact factor: 5.075

Review 8.  Small Animal Models of Respiratory Viral Infection Related to Asthma.

Authors:  Mingyuan Han; Charu Rajput; Tomoko Ishikawa; Caitlin R Jarman; Julie Lee; Marc B Hershenson
Journal:  Viruses       Date:  2018-12-01       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.